
    
      This study is a prospective randomized, double-blind, double-dummy, multicentre, 2-arm (1
      Active, Active Control) comparative parallel group study to compare the safety and efficacy
      of solifenacin with oxybutynin immediate-release (IR) for the treatment of overactive bladder
      (OAB).
    
  